Menawat Arun Swarup's Form 4 filing
Profound Medical Corp. (PROF) · filed May 20, 2025
- Accession no.
- 0001171843-25-003336
- Filed
- May 20, 2025
- Trade date
- May 15-16, 2025
- Filing delay
- 5 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market purchases total $100.2K. It was filed 5 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Menawat Arun SwarupCIK 0001685893 | Director, Officer (CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 15, 2025 | Common Shares | PPurchaseAcquired | +10,003 | $4.33 | +$43,312.99 | 575,062 | Direct | |
| May 16, 2025 | Common Shares | PPurchaseAcquired | +12,027 | $4.73 | +$56,887.71 | 587,089 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.